ICH E12 Principles for clinical evaluation of new antihypertensive drugs
| Current effective version |
|
| Reference number | CPMP/ICH/541/00 |
| Published | 01/06/2000 |
| Effective from | 01/06/2000 |
| Keywords | Hypertension, antihypertensives, anti-hypertensive drugs, fixed combination products |
| Description | This document describes core principles for the evaluation of antihypertensives that are accepted in the three ICH regions. Since there are some region-specific differences that have not been harmonised, it should be considered an "ICH principle document" rather than an "ICH guideline". |
Related contnent
- ICH E1 Population exposure: the extent of population exposure to assess clinical safety
- ICH E3 Structure and content of clinical study reports
- ICH E4 Dose response information to support drug registration
- ICH E5 (R1) Ethnic factors in the acceptability of foreign clinical data
- ICH E6 (R1) Good clinical practice
- ICH E7 Studies in support of special populations: geriatrics
- ICH E8 General considerations for clinical trials
- ICH E9 Statistical principles for clinical trials
- ICH E10 Choice of control group in clinical trials
- ICH E11 Clinical investigation of medicinal products in the paediatric population